Liminal BioSciences Inc. — Form D

Liminal BioSciences Inc. of LAVAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-24. The offering totals $37.1M, of which $37.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Simon Victor BestDirectorLaval, A8
Gary Victor BridgerDirectorLaval, A8
Stefan Victor ClulowDirectorLaval, A8
Kenneth Victor GalbraithDirectorLaval, A8
Charles Victor KenworthyDirectorLaval, A8
Neil Victor KlompasDirectorLaval, A8
Paul Victor MesburisDirectorLaval, A8
Zachary Victor NewtonDirectorLaval, A8
Timothy Victor WachDirectorLaval, A8
Kenneth Victor GalbraithExecutive OfficerLaval, A8
Martin Victor LeclercExecutive OfficerLaval, A8
John Victor MoranExecutive OfficerLaval, A8
Bruce Victor PritchardExecutive OfficerLaval, A8
Patrick Victor SantoreExecutive OfficerLaval, A8
Gary J BridgerDirectorBOSTON, MA
Bruce PritchardExecutive OfficerCambridge, X0
Moira DanielsExecutive OfficerCambridge, X0
Marie IskraExecutive OfficerLaval, A8
Martin LeclercExecutive OfficerLaval, A8
Murielle LortieExecutive OfficerLaval, A8
Patrick SartoreExecutive OfficerLaval, A8
Timothy Steven WachDirectorLaval, A8
Eugene A SiklosDirectorLaval, A8
Alek A KrstajicDirectorLaval, A8
Simon G BestDirectorLaval, A8

Other filings by this issuer (1)

FiledFormOfferingSold
2020-11-18D$30.0M$30.0M

More